Shurin MR - Search Results

1

Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function.

Katsenelson NS, Shurin GV, Bykovskaia SN, Shogan J, Shurin MR. Katsenelson NS, et al. Among authors: shurin gv, shurin mr. Mod Pathol. 2001 Jan;14(1):40-5. doi: 10.1038/modpathol.3880254. Mod Pathol. 2001. PMID: 11211308

2

Dendritic cells presenting tumor antigen.

Shurin MR. Shurin MR. Cancer Immunol Immunother. 1996 Nov;43(3):158-64. doi: 10.1007/s002620050317. Cancer Immunol Immunother. 1996. PMID: 9001569 Review.

3

Dendritic cell based therapy of cancer.

Lotze MT, Shurin M, Davis I, Amoscato A, Storkus WJ. Lotze MT, et al. Adv Exp Med Biol. 1997;417:551-69. doi: 10.1007/978-1-4757-9966-8_91. Adv Exp Med Biol. 1997. PMID: 9286419 Review. No abstract available.

4

FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.

Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. Esche C, et al. Among authors: shurin mr. Cancer Res. 1998 Feb 1;58(3):380-3. Cancer Res. 1998. PMID: 9458075

5

CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth.

Esche C, Gambotto A, Satoh Y, Gerein V, Robbins PD, Watkins SC, Lotze MT, Shurin MR. Esche C, et al. Among authors: shurin mr. Eur J Immunol. 1999 Jul;29(7):2148-55. doi: 10.1002/(SICI)1521-4141(199907)29:07<2148::AID-IMMU2148>3.0.CO;2-F. Eur J Immunol. 1999. PMID: 10427977 Free article.

6

Tumor's other immune targets: dendritic cells.

Esche C, Lokshin A, Shurin GV, Gastman BR, Rabinowich H, Watkins SC, Lotze MT, Shurin MR. Esche C, et al. Among authors: shurin gv, shurin mr. J Leukoc Biol. 1999 Aug;66(2):336-44. doi: 10.1002/jlb.66.2.336. J Leukoc Biol. 1999. PMID: 10449178

7

The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15.

Bykovskaia SN, Buffo M, Zhang H, Bunker M, Levitt ML, Agha M, Marks S, Evans C, Ellis P, Shurin MR, Shogan J. Bykovskaia SN, et al. Among authors: shurin mr. J Leukoc Biol. 1999 Oct;66(4):659-66. doi: 10.1002/jlb.66.4.659. J Leukoc Biol. 1999. PMID: 10534123

8

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Lotze MT, Shurin M, Esche C, Tahara H, Storkus W, Kirkwood JM, Whiteside TL, Elder EM, Okada H, Robbins P. Lotze MT, et al. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S61-6. Cancer J Sci Am. 2000. PMID: 10685662 Review.

9

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

Pirtskhalaishvili G, Shurin GV, Gambotto A, Esche C, Wahl M, Yurkovetsky ZR, Robbins PD, Shurin MR. Pirtskhalaishvili G, et al. Among authors: shurin gv, shurin mr. J Immunol. 2000 Aug 15;165(4):1956-64. doi: 10.4049/jimmunol.165.4.1956. J Immunol. 2000. PMID: 10925278

10

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins.

Pirtskhalaishvili G, Shurin GV, Esche C, Cai Q, Salup RR, Bykovskaia SN, Lotze MT, Shurin MR. Pirtskhalaishvili G, et al. Among authors: shurin gv, shurin mr. Br J Cancer. 2000 Aug;83(4):506-13. doi: 10.1054/bjoc.2000.1289. Br J Cancer. 2000. PMID: 10945499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters